Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review

American Journal of Gastroenterology

Volumn 105, Issue 3, 2010, Pages 525-539

  Jackson, C A ^a   Clatworthy, J ^a   Robinson, A ^b   Horne, Rob ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; STEROID; SULFAPYRIDINE;

CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; ENTERITIS; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK FACTOR; SELF REPORT; SOCIAL SUPPORT; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULCERATIVE COLITIS; VISUAL ANALOG SCALE;

ADULT; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS; TREATMENT REFUSAL;

EID: 77949265473     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.685     Document Type: Review

References (62)

1. Horne R, Keller I. Interventions to facilitate adherence. In:Horne R, Weinman J, Barber N, et al (eds). Concordance, Adherence and Compliance in Medicine Taking:A Conceptual Map and Research Priorities. National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO: London, 2006.
2. Nunes V, Neilson J, O ' Flynn N, et al. Clinical Guidelines and Evidence Review for Medicines Adherence:Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. National Collaborating Centre for Primary Care and Royal College of General Practitioners: London, 2009.
3. Higgins PDR, Rubin DT, Kaulback K, et al. Systematic review:impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009;29:247-257
4. Biancone L, Michetti P, Travis S, et al. European evidence-based consensus on the management of ulcerative colitis:special situations. J Crohn's Colitis 2008;2:63-92. (Pubitemid 351179489)
5. National Council on Patient Information and Education. Enhancing Prescription Medicine Adherence:A National Action Plan. National Council on Patient Information and Education:Rockville, MD, 2007.
6. Bassi A, Dodd S, Williamson P, et al. Cost of illness of inflammatory bowel disease in the UK:a single centre retrospective study. Gut 2004;53:1471-1478
7. World Health Organisation. Adherence to Long-Term Therapies:Evidence for Action. World Health Organisation:Geneva, 2003.
8. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. JAMA 2002;288:2880-2883
9. Hawthorne AB, Rubin G, Ghosh S. Review article:medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008;27:1157-1166
10. Kane SV. Systematic review:adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006;23:577-585
11. Kane SV. Overcoming adherence issues in ulcerative colitis. Gastroenterol Hepatol 2007;3:795-799
12. Kane VS, Brixner D, Rubin DT, et al. The complexity of compliance and persistence in ulcerative colitis. Gastroenterol Hepatol 2007;3 (Suppl 28):1-9.
13. Lopez-Sanroman A, Bermejo F. Review article:how to control and improve adherence to therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2006;24 (Suppl 3):45-49
14. Robinson A. Review article:improving adherence to medication in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008;27 (Suppl 1): 9-14.
15. Turnbough L, Wilson L. " Take your medicine ":nonadherence issues in patients with ulcerative colitis. Gastroenterol Nurs 2007;30:212-7;quiz 18-19
16. Centre for Reviews and Dissemination. Systematic reviews. 2009 (updated 2009 July;cited 2009 July) http://www.york.ac.uk/inst/crd/systematic-reviews- book.htm.
17. National Institute for Health and Clinical Excellence. NICE Public Health Guidance Methods Manual. 2006 (updated 2006;cited 2009 July) http:// www.nice.org.uk/media/69E/BD/CPHEMethodsManual.pdf.
18. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982;4:333-336
19. Haynes RB, Taylor DW, Sackett DL (eds). Compliance in Health Care. Johns Hopkins University:Baltimore, 1979.
20. Bernal I, Domenech E, Garcia-Planella E, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006;51:2165-2169
21. Bokemeyer B, Teml A, Roggel C, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther 2007;26:217-225
22. Cerveny P, Bortlik M, Kubena A, et al. Nonadherence in inflammatory bowel disease:results of factor analysis. Inflamm Bowel Dis 2007;13:1244-1249
23. Cerveny P, Bortlik M, Vlcek J, et al. Non-adherence to treatment in inflammatory bowel disease in Czech Republic. J Crohn's Colitis 2007;1:77-81.
24. Dewulf NDLS, Monteiro RA, Passos ADC, et al. Compliance to drug therapy in inflammatory bowel diseases outpatients from an University hospital [Portuguese]. Arquivos de Gastroenterologia 2007;44:289-296
25. D'Inca R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inflammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166-172
26. Ediger JP, Walker JR, GraffL, et al. Predictors of medication adherence in inflammatory bowel disease [see comment]. Am J Gastroenterol 2007;102:1417-1426
27. Horne R, Parham R, Driscoll R, et al. Patients'attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:837-844
28. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis [see comment]. Am J Gastroenterol 2001;96:2929-2933
29. Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin Gastroenterol Hepatol 2003;1:170-173
30. Karbach U, Degen I, Ewe K. Extent of drug compliance in Crohn disease patients-study of a special ambulatory care unit of a University clinic. Z Gastroenterol 1984;22:573-579
31. Lopez San Roman A, Bermejo F, Carrera E, et al. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249-257 (Pubitemid 40755660)
32. Mantzaris GJ, Roussos A, Kalantzis C, et al. How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission? Inflamm Bowel Dis 2007;13:446-450
33. Nigro G, Angelini G, Grosso SB, et al. Psychiatric predictors of noncompliance in inflammatory bowel disease:psychiatry and compliance [see comment. J Clin Gastroenterol 2001;32:66-8.
34. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-1544
35. Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:191-198
36. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease:a randomized controlled trial. Can J Gastroenterol 2005;19:235-244
37. Sanderson S, Tatt ID, Higgins JPT. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology:a systematic review and annotated bibliography. Int J Epidemiol 2007;36:666-676
38. Vandenbroucke JP, Elm Ev, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE):Explanation and Elaboration. Ann Intern Med 2007;147:W163-94.
39. National Institute for Health and Clinical Excellence. NICE Public Health Guidance Methods Manual. 2006 (cited) http://www.nice.org.uk/media/ 69E/BD/CPHEMethodsManual.pdf.
40. Weightman AL, Mann MK, Sander L, Turley RL. Project Methodology 5. University of Wales College of Medicine:Cardiffpp. 26-28, 2004.
41. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease [see comment]. Am J Gastroenterol 2003;98:1535-1544
42. Field A. Discovering Statistics Using SPSS. Sage:London, 2005.
43. Bland JM, Altman DG. Statistics notes:multiple significance tests:the Bonferroni method. BMJ 1995;310:170.
44. Vitolins MZ, Rand CS, Rapp SR, et al. Measuring adherence to behavioral and medical interventions. Control Clin Trials 2000;21 (Suppl 5):188S-94S.
45. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-1090
46. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients:is there a solution to the problem? Ann Asthma Immunol 1997;79:177-186
47. Horne R, Clatworthy J. Adherence to advice and treatment. In:French DN, Vedhara K, Kaptein AD, et al (eds). Health Psychology, 2nd edn 2010. Oxford:BPS Blackwell.
48. Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 2007;58:1187-1192
49. Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence:a summary of the literature. Med Care 2004;42:649-652
50. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-1310
51. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment:a review of literature. J Behav Med 2008;31:213-224
52. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment:meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107
53. Pound P, Britten N, Morgan M, et al. Resisting medicines:a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-155
54. Horne R, Weinman J, Barber N, et al. Concordance, Adherence and Compliance in Medicine Taking:A conceptual Map and Research Priorities. National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO:London, 2006.
55. Hall A, Porrett T, Cox C. Factors affecting medication compliance in inflammatory bowel disease. Gastroenterol Nurs 2006;4:31-40.
56. Moshkovska T, Stone M, Baker R, et al. Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis. Inflamm Bowel Dis 2008;14:763-768
57. Hall NJ, Rubin GP, Hungin APS, et al. Medication beliefs among patients with inflammatory bowel disease who report low quality of life:a qualitative study. BMC Gastroenterol 2007;7:20.
58. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, issue 2. art. no.: CD000011. DOI:10.1002/14651858.CD000011.pub3. (Pubitemid 351807324)
59. Egger M, Schneider M, Smith GD. Meta-analysis spurious precision? Metaanalysis of observational studies. BMJ 1998;316:140-144
60. Jefferson T, Di Pietrantonj C, Debalini MG, et al. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines:systematic review. BMJ 2009;338 (Feb 12):b354.
61. Hasher L, Goldstein D, Toppino T. Frequency and the conference of referential validity. J Verbal Learn Verbal Behav 1977;88:297-306.
62. Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am J Gastroenterol 1999;94:1733-1742